Biomedical Engineering Reference
In-Depth Information
44. Cuzick, J.,
Use of luteinising-hormone-releasing hormone agonists
as adjuvant treatment in premenopausal patients with hormone-
receptor-positive breast cancer: a meta-analysis of individual patient
data from randomised adjuvant trials.
et al.
Lancet
369
, 1711-1723
(2007).
45. Hughes, L.L.,
Efficacy of radiotherapy for ovarian ablation: results
of a breast intergroup study.
et al.
, 969-972 (2004).
46. Adjuvant tamoxifen in the management of operable breast cancer:
the Scottish Trial. Report from the Breast Cancer Trials Committee,
Scottish Cancer Trials Office (MRC), Edinburgh.
Cancer
101
Lancet
2
, 171-175
(1987).
47. Fisher, B.,
A randomized clinical trial evaluating tamoxifen in
the treatment of patients with node-negative breast cancer who
have estrogen-receptor-positive tumors.
et al.
N Engl J Med
320
, 479-484
(1989).
48. Baum, M.,
Anastrozole alone or in combination with tamoxifen
versus tamoxifen alone for adjuvant treatment of postmenopausal
women with early breast cancer: first results of the ATAC randomised
trial.
et al.
Lancet
359
, 2131-2139 (2002).
49. Howell, A.,
Results of the ATAC (Arimidex, Tamoxifen, Alone or in
Combination) trial after completion of 5 years' adjuvant treatment for
breast cancer.
et al.
Lancet
365
, 60-62 (2005).
50. Jakesz, R.,
Switching of postmenopausal women with endocrine-
responsive early breast cancer to anastrozole after 2 years' adjuvant
tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial.
et al.
Lancet
, 455-462 (2005).
51. Boccardo, F.,
366
Switching to an aromatase inhibitor provides
mortality benefit in early breast carcinoma: pooled analysis of 2
consecutive trials.
et al.
Cancer
109
, 1060-1067 (2007).
52. Jonat, W.,
Effectiveness of switching from adjuvant tamoxifen to
anastrozole in postmenopausal women with hormone-sensitive early-
stage breast cancer: a meta-analysis.
et al.
Lancet Oncol
7
, 991-996 (2006).
53. Thurlimann, B.,
A comparison of letrozole and tamoxifen in
postmenopausal women with early breast cancer.
et al.
N Engl J Med
353
,
2747-2757 (2005).
54. Coates, A.S.,
Five years of letrozole compared with tamoxifen as
initial adjuvant therapy for postmenopausal women with endocrine-
responsive early breast cancer: update of study BIG 1-98.
et al.
J Clin Oncol
25
, 486-492 (2007).
